Primaquine

from Wikipedia, the free encyclopedia
Structural formula
Structural formula of primaquine
1: 1 mixture of the stereoisomers - ( R ) -form (top) and ( S ) -form (bottom)
General
Non-proprietary name Primaquine
other names
  • (±) - N 4 - (6-methoxyquinolin-8-yl) pentane-1,4-diamine
  • ( RS ) - N 4 - (6-Methoxyquinolin-8-yl) pentane-1,4-diamine
  • DL - N 4 - (6-methoxyquinolin-8-yl) pentane-1,4-diamine
  • Latin : Primaquinum
Molecular formula C 15 H 21 N 3 O
Brief description
  • viscous liquid (primaquine)
  • orange-red, odorless powder with a bitter taste (primaquine bisphosphonate)
External identifiers / databases
CAS number
  • 90-34-6
  • 63-45-6 (phosphate 1: 2)
EC number 201-987-2
ECHA InfoCard 100.001.807
PubChem 4908
ChemSpider 4739
DrugBank DB01087
Wikidata Q419834
Drug information
ATC code

P01 BA03

Drug class

Antiprotozoal drugs

properties
Molar mass 259.35 g · mol -1
Melting point

<25 ° C

boiling point

175-179 ° C (26.7 Pa )

solubility
safety instructions
Please note the exemption from the labeling requirement for drugs, medical devices, cosmetics, food and animal feed
GHS labeling of hazardous substances

Bisphosphate

06 - Toxic or very toxic

danger

H and P phrases H: 301
P: 301 + 310
Toxicological data

100 mg kg −1 ( LD 50mouseoral )

As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Primaquine is a medicinal substance that is suitable for combating and treating malaria , especially tertian malaria.

It has been used since 1926 and is particularly effective against the extra-erythrocytic parasite stages, especially with Plasmodium vivax . The interaction of primaquine with the double-stranded DNA of the plasmodia leads to an inhibition of protein biosynthesis. The intake is limited to 2 weeks. Side effects are very rare, but serious in the case of glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency). In addition, taking primaquine can lead to anemia or headaches .

The active ingredient is approved under the trade names A-PQ ® NL and Primaquine ® CDN (as of October 2009).

Side effects

During the Second World War it was noticed that African American soldiers reacted more frequently to the malaria drug primaquine with a breakdown of red blood cells (haemolysis). After the war, a defect in the enzyme glucose-6-phosphate dehydrogenase was recognized as the cause . It also found that people from the Mediterranean area can also be affected. In addition, serious side effects are known from an interaction with grapefruit.

literature

  • JK Baird, SL Hoffman: Primaquine therapy for malaria. In: Clin Infect Dis . 39, 2004, pp. 1336-1345. PMID 15494911
  • Heinz Lüllmann, Klaus Mohr, Martin Wehling, Lutz Hein: Pharmacology and toxicology: Understanding drug effects - using drugs in a targeted manner. Thieme, Stuttgart.

Individual evidence

  1. a b c Entry on primaquine. In: Römpp Online . Georg Thieme Verlag, accessed on May 29, 2014.
  2. ^ A b Poisons Information Monograph (PIM) for Primaquine , accessed November 2, 2014.
  3. a b Entry on primaquine in the ChemIDplus database of the United States National Library of Medicine (NLM) .
  4. a b Datasheet Primaquine bisphosphate from Sigma-Aldrich , accessed on April 22, 2011 ( PDF ).
  5. AS Alving, PE Ccarson et al.: Enzymatic deficiency in primaquine-sensitive erythrocytes. In: Science. Volume 124, Number 3220, September 1956, pp. 484-485. PMID 13360274 .
  6. medicine-transparent.at